Clinical Trial Update: Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating antenatal melatonin supplementation for neuroprotection in fetal growth restriction and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Preterm Birth
• Stillbirth

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Monash University | Conditions: Fetal Growth Retardation, Stillbirth and Fetal Death | Phase 3 | Status: RECRUITING